Literature DB >> 16785804

F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.

Gerhard W Goerres1, Adrian Forster, Daniel Uebelhart, Burkhardt Seifert, Valerie Treyer, Beat Michel, Gustav K von Schulthess, Achim H Kaim.   

Abstract

UNLABELLED: PURPOSE OF REPORT: F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) can be used to image synovitis in patients with rheumatoid arthritis (RA). The aim of this study was to evaluate if a simple scoring system based on visual assessment of FDG joint uptake correlates with the clinical assessment of patients with RA undergoing antiinflammatory treatment.
MATERIALS AND METHODS: Seven patients with active RA underwent whole-body FDG PET and clinical assessment before and after treatment with the antitumor necrosis factor alpha antibody (infliximab). A PET total joint score, ie, the sum of all scores based on FDG uptake intensity between zero and 4 in 28 joints, was correlated with a total joint score based on the clinical disease activity in the same joints using a Spearman rank correlation.
RESULTS: The PET based total joint score was similarly high before onset as was the clinical total joint score. The decrease of FDG joint uptake in the follow-up PET scans correlated significantly with the clinical assessment. Additionally, synovial FDG uptake was found in extraarticular sites such as tendon sheaths and bursae.
CONCLUSIONS: Visual assessment of FDG uptake shows a significant correlation with clinical evaluation of disease activity in patients with RA undergoing antiinflammatory treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785804     DOI: 10.1097/01.rlu.0000222678.95218.42

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  38 in total

Review 1.  Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.

Authors:  Jeffrey T Gu; Linda Nguyen; Abhijit J Chaudhari; John D MacKenzie
Journal:  Top Magn Reson Imaging       Date:  2011-04

Review 2.  Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Authors:  Kathleen Carey; Babak Saboury; Sandip Basu; Alex Brothers; Alexis Ogdie; Tom Werner; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-14       Impact factor: 9.236

3.  High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.

Authors:  Abhijit J Chaudhari; Andrea Ferrero; Felipe Godinez; Kai Yang; David K Shelton; John C Hunter; Stanley M Naguwa; John M Boone; Siba P Raychaudhuri; Ramsey D Badawi
Journal:  Br J Radiol       Date:  2016-04-25       Impact factor: 3.039

4.  Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs.

Authors:  Anne Roivainen; Sannamari Hautaniemi; Timo Möttönen; Pirjo Nuutila; Vesa Oikonen; Riitta Parkkola; Luminita Pricop; Rudyard Ress; Nicholas Seneca; Marko Seppänen; Timo Yli-Kerttula
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-15       Impact factor: 9.236

5.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

6.  PET assessment of disease activity in children with juvenile idiopathic arthritis.

Authors:  Ukihide Tateishi; Tomoyuki Imagawa; Noriko Kanezawa; Tetsuhiko Okabe; Kazuya Shizukuishi; Tomio Inoue; Shumpei Yokota
Journal:  Pediatr Radiol       Date:  2010-06-04

Review 7.  Rheumatoid arthritis: Nuclear Medicine state-of-the-art imaging.

Authors:  Paulo Henrique Rosado-de-Castro; Sergio Augusto Lopes de Souza; Dângelo Alexandre; Lea Mirian Barbosa da Fonseca; Bianca Gutfilen
Journal:  World J Orthop       Date:  2014-07-18

8.  Evaluating disease activity in patients with ankylosing spondylitis and rheumatoid arthritis using 99mtc-glucosamine.

Authors:  Nicholas Manolios; Marina Ali; Bradley Camden; Elham Aflaky; Katrina Pavic; Andrew Markewycz; Robert De Costa; Socrates Angelides
Journal:  Eur J Rheumatol       Date:  2016-04-05

9.  Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies.

Authors:  Vishu Vijayant; Manjit Sarma; Hrushikesh Aurangabadkar; Lata Bichile; Sandip Basu
Journal:  World J Radiol       Date:  2012-12-28

10.  In vivo quantification of mouse autoimmune arthritis by PET/CT.

Authors:  Smriti Kundu-Raychaudhuri; Anupam Mitra; Ananya Datta-Mitra; Abhijit J Chaudhari; Siba P Raychaudhuri
Journal:  Int J Rheum Dis       Date:  2014-06-26       Impact factor: 2.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.